| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $146K | +21.7% |
| R&D Expense | $4.0M | +14.8% |
| SG&A Expense | $11.3M | -27.3% |
| Operating Income | -$15.2M | +19.8% |
| Net Income | -$14.4M | +22.1% |
| EPS (Basic) | -$3.42 | +33.1% |
| EPS (Diluted) | -$3.42 | +33.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $884K | -47.3% |
| Short-term Investments | $10.2M | -22.1% |
| Accounts Receivable | $19K | +20.6% |
| Current Assets | $11.4M | -24.7% |
| Total Assets | $12.6M | -23.3% |
| Current Liabilities | $1.1M | +141.5% |
| Total Liabilities | $1.1M | +76.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -9.5% |
| Capital Expenditures | $171K | -35.5% |
| Investing Cash Flow | $3.3M | +124.1% |
| Financing Cash Flow | $2.4M | — |
| Free Cash Flow | -$6.6M | -7.6% |
| Stockholders' Equity |
| $11.5M |
| -27.1% |